Repligen (RGEN) News Today $150.81 +4.88 (+3.34%) Closing price 10/8/2025 04:00 PM EasternExtended Trading$151.48 +0.66 (+0.44%) As of 10/8/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RGEN Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Top 10 Stock Recommendations You Can’t Miss Amid Growing AI Bubble FearsOctober 8 at 8:34 AM | insidermonkey.comEvercore ISI Group Maintains Repligen (RGEN) Outperform RecommendationOctober 8 at 2:05 AM | msn.comRepligen (NASDAQ:RGEN) Price Target Raised to $175.00 at Evercore ISIOctober 7 at 2:06 PM | marketbeat.comRepligen Corporation $RGEN Holdings Raised by Slow Capital Inc.October 7 at 7:00 AM | marketbeat.comDrug Development Inputs & Services Stocks Q2 Recap: Benchmarking Medpace (NASDAQ:MEDP)October 6 at 8:53 AM | msn.com111 Capital Purchases New Holdings in Repligen Corporation $RGENOctober 6 at 4:27 AM | marketbeat.comRepligen (NASDAQ:RGEN) Upgraded at Hsbc Global ResOctober 3, 2025 | marketbeat.comBarclays Maintains Repligen (RGEN) Overweight RecommendationOctober 2, 2025 | msn.comRepligen price target raised to $160 from $150 at BarclaysOctober 2, 2025 | msn.comWhat 8 Analyst Ratings Have To Say About RepligenOctober 1, 2025 | benzinga.comWhy Is Repligen (RGEN) Stock Soaring TodayOctober 1, 2025 | msn.comRepligen initiated with a Buy at HSBCOctober 1, 2025 | msn.comRepligen’s Growth Potential: A Buy Rating Backed by Innovation and Strategic PositioningOctober 1, 2025 | tipranks.comPark Avenue Securities LLC Invests $340,000 in Repligen Corporation $RGENOctober 1, 2025 | marketbeat.comRepligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To KnowSeptember 30, 2025 | msn.comRepligen (NASDAQ:RGEN) Trading Up 4.5% - Time to Buy?September 30, 2025 | marketbeat.comBanque Pictet & Cie SA Has $2.58 Million Position in Repligen Corporation $RGENSeptember 27, 2025 | marketbeat.comRepligen Corporation $RGEN Shares Bought by Congress Asset Management Co.September 27, 2025 | marketbeat.comRepligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 TranscriptSeptember 25, 2025 | seekingalpha.comRepligen Corporation (RGEN) Presents at Bank of America Global Healthcare Conference 2025 - SlideshowSeptember 25, 2025 | seekingalpha.comRiverbridge Partners LLC Lowers Stock Position in Repligen Corporation $RGENSeptember 25, 2025 | marketbeat.com3 Reasons to Sell RGEN and 1 Stock to Buy InsteadSeptember 24, 2025 | msn.comDrug Development Inputs & Services Stocks Q2 Results: Benchmarking Repligen (NASDAQ:RGEN)September 23, 2025 | msn.comEvercore ISI Group Upgrades Repligen (RGEN)September 22, 2025 | msn.comRepligen Corporation (NASDAQ:RGEN) Receives Consensus Rating of "Moderate Buy" from AnalystsSeptember 19, 2025 | marketbeat.comThree Stocks Estimated To Be Below Fair Value In September 2025September 17, 2025 | finance.yahoo.comKrilogy Financial LLC Invests $2.51 Million in Repligen Corporation $RGENSeptember 17, 2025 | marketbeat.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Raises Position in Repligen Corporation $RGENSeptember 17, 2025 | marketbeat.comRepligen (RGEN) Stock Is Up, What You Need To KnowSeptember 16, 2025 | finance.yahoo.comStrs Ohio Buys Shares of 47,700 Repligen Corporation $RGENSeptember 16, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for Repligen Q4 Earnings?September 16, 2025 | marketbeat.comWoodline Partners LP Buys New Shares in Repligen Corporation $RGENSeptember 15, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Given New $135.00 Price Target at Jefferies Financial GroupSeptember 14, 2025 | marketbeat.comOsterweis Capital Management Inc. Has $9.26 Million Position in Repligen Corporation $RGENSeptember 14, 2025 | marketbeat.comUnited Services Automobile Association Acquires New Shares in Repligen Corporation $RGENSeptember 13, 2025 | marketbeat.comWhy Repligen (RGEN) Stock Is Down TodaySeptember 12, 2025 | msn.comIs There An Opportunity With Repligen Corporation's (NASDAQ:RGEN) 29% Undervaluation?September 10, 2025 | uk.finance.yahoo.comRBC Capital Reaffirms Their Buy Rating on Repligen (RGEN)September 10, 2025 | theglobeandmail.comFred Alger Management LLC Boosts Position in Repligen Corporation $RGENSeptember 10, 2025 | marketbeat.comDynamic Technology Lab Private Ltd Raises Stake in Repligen Corporation $RGENSeptember 10, 2025 | marketbeat.comScientech Research LLC Makes New Investment in Repligen Corporation $RGENSeptember 9, 2025 | marketbeat.comRepligen Corporation $RGEN Shares Sold by Polar Asset Management Partners Inc.September 9, 2025 | marketbeat.comSandler Capital Management Sells 8,004 Shares of Repligen Corporation $RGENSeptember 8, 2025 | marketbeat.comCinctive Capital Management LP Sells 59,424 Shares of Repligen Corporation $RGENSeptember 8, 2025 | marketbeat.comGranahan Investment Management LLC Trims Stake in Repligen Corporation $RGENSeptember 7, 2025 | marketbeat.comEFG Asset Management North America Corp. Has $1.65 Million Stake in Repligen Corporation $RGENSeptember 7, 2025 | marketbeat.comAlliancebernstein L.P. Purchases 13,284 Shares of Repligen Corporation $RGENSeptember 7, 2025 | marketbeat.comAlyeska Investment Group L.P. Boosts Holdings in Repligen Corporation $RGENSeptember 6, 2025 | marketbeat.comRepligen (NASDAQ:RGEN) Earns "Buy" Rating from HC WainwrightSeptember 5, 2025 | marketbeat.comAWM Investment Company Inc. Cuts Stock Holdings in Repligen Corporation $RGENSeptember 5, 2025 | marketbeat.com Get Repligen News Delivered to You Automatically Sign up to receive the latest news and ratings for RGEN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RGEN Media Mentions By Week RGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGEN News Sentiment▼0.590.63▲Average Medical News Sentiment RGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGEN Articles This Week▼1211▲RGEN Articles Average Week Get the Latest News and Ratings for RGEN and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Repligen and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Bio-Techne News Agilent Technologies News Danaher News Mettler-Toledo International News Thermo Fisher Scientific News Biogen News United Therapeutics News Incyte News Neurocrine Biosciences News Ionis Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGEN) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
